Literature DB >> 24077678

The biophysics of renal sympathetic denervation using radiofrequency energy.

Hitesh C Patel, Paramdeep S Dhillon, Felix Mahfoud, Alistair C Lindsay, Carl Hayward, Sabine Ernst, Alexander R Lyon, Stuart D Rosen, Carlo di Mario.   

Abstract

Renal sympathetic denervation is currently performed in the treatment of resistant hypertension by interventionists who otherwise do not typically use radiofrequency (RF) energy ablation in their clinical practice. Adequate RF lesion formation is dependent upon good electrode-tissue contact, power delivery, electrode-tissue interface temperature, target-tissue impedance and the size of the catheter's active electrode. There is significant interplay between these variables and hence an appreciation of the biophysical determinants of RF lesion formation is required to provide effective and safe clinical care to our patients. In this review article, we summarize the biophysics of RF ablation and explain why and how complications of renal sympathetic denervation may occur and discuss methods to minimise them.

Entities:  

Mesh:

Year:  2014        PMID: 24077678     DOI: 10.1007/s00392-013-0618-6

Source DB:  PubMed          Journal:  Clin Res Cardiol        ISSN: 1861-0684            Impact factor:   5.460


  26 in total

1.  Hypertensive vascular disease; results of and indications for splanchnicectomy.

Authors:  R H SMITHWICK
Journal:  J Chronic Dis       Date:  1955-05

2.  Micro-anatomy of the renal sympathetic nervous system: a human postmortem histologic study.

Authors:  Daniel S Atherton; Nicholas L Deep; Farrell O Mendelsohn
Journal:  Clin Anat       Date:  2011-10-04       Impact factor: 2.414

3.  Renal hemodynamics and renal function after catheter-based renal sympathetic denervation in patients with resistant hypertension.

Authors:  Felix Mahfoud; Bodo Cremers; Julia Janker; Britta Link; Oliver Vonend; Christian Ukena; Dominik Linz; Roland Schmieder; Lars Christian Rump; Ingrid Kindermann; Paul Andrew Sobotka; Henry Krum; Bruno Scheller; Markus Schlaich; Ulrich Laufs; Michael Böhm
Journal:  Hypertension       Date:  2012-06-25       Impact factor: 10.190

4.  Popping phenomena in temperature-controlled radiofrequency ablation: when and why do they occur?

Authors:  O J Eick; B Gerritse; B Schumacher
Journal:  Pacing Clin Electrophysiol       Date:  2000-02       Impact factor: 1.976

5.  Expert consensus document from the European Society of Cardiology on catheter-based renal denervation.

Authors:  Felix Mahfoud; Thomas Felix Lüscher; Bert Andersson; Iris Baumgartner; Renata Cifkova; Carlo Dimario; Pieter Doevendans; Robert Fagard; Jean Fajadet; Michel Komajda; Thierry Lefèvre; Chaim Lotan; Horst Sievert; Massimo Volpe; Petr Widimsky; William Wijns; Bryan Williams; Stephan Windecker; Adam Witkowski; Thomas Zeller; Michael Böhm
Journal:  Eur Heart J       Date:  2013-04-25       Impact factor: 29.983

6.  Electrophysiologic and histologic observations of chronic atrioventricular block induced by closed-chest catheter desiccation with radiofrequency energy.

Authors:  S K Huang; S Bharati; M Lev; F I Marcus
Journal:  Pacing Clin Electrophysiol       Date:  1987-07       Impact factor: 1.976

7.  Closed-chest atrioventricular junction ablation by high-frequency energy transcatheter desiccation.

Authors:  T Lavergne; L Guize; J Y Le Heuzey; P Carcone; J Geslin; M T Cousin
Journal:  Lancet       Date:  1986-10-11       Impact factor: 79.321

8.  Comparison of in vivo tissue temperature profile and lesion geometry for radiofrequency ablation with a saline-irrigated electrode versus temperature control in a canine thigh muscle preparation.

Authors:  H Nakagawa; W S Yamanashi; J V Pitha; M Arruda; X Wang; K Ohtomo; K J Beckman; J H McClelland; R Lazzara; W M Jackman
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

9.  High incidence of thrombus formation without impedance rise during radiofrequency ablation using electrode temperature control.

Authors:  Kagari Matsudaira; Hiroshi Nakagawa; Fred H M Wittkampf; William S Yamanashi; Shinobu Imai; Jan V Pitha; Ralph Lazzara; Warren M Jackman
Journal:  Pacing Clin Electrophysiol       Date:  2003-05       Impact factor: 1.976

10.  Sympatho-renal axis in chronic disease.

Authors:  Paul A Sobotka; Felix Mahfoud; Markus P Schlaich; Uta C Hoppe; Michael Böhm; Henry Krum
Journal:  Clin Res Cardiol       Date:  2011-06-19       Impact factor: 5.460

View more
  15 in total

1.  Neuropeptide Y as an indicator of successful alterations in sympathetic nervous activity after renal sympathetic denervation.

Authors:  Oliver Dörr; Sebastian Ewen; Christoph Liebetrau; Helge Möllmann; Luise Gaede; Dominik Linz; Mathias Hohl; Christian Troidl; Timm Bauer; Michael Böhm; Christian Hamm; Felix Mahfoud; Holger Nef
Journal:  Clin Res Cardiol       Date:  2015-05-26       Impact factor: 5.460

2.  Renal sympathetic denervation: effect on ambulatory blood pressure and blood pressure variability in patients with treatment-resistant hypertension. The ReShape CV-risk study.

Authors:  A Miroslawska; M Solbu; E Skjølsvik; I Toft; T K Steigen
Journal:  J Hum Hypertens       Date:  2015-07-02       Impact factor: 3.012

3.  Second denervation in a patient with resistant hypertension.

Authors:  Jose Carlos Prado; Dayan Salado; Luis Miguel Ruilope; Julian Segura
Journal:  Clin Res Cardiol       Date:  2016-06-08       Impact factor: 5.460

4.  Beneficial effects of renal sympathetic denervation on cardiovascular inflammation and remodeling in essential hypertension.

Authors:  Oliver Dörr; Christoph Liebetrau; Helge Möllmann; Felix Mahfoud; Sebastian Ewen; Luise Gaede; Christian Troidl; Jedrzej Hoffmann; Nikolai Busch; Gerald Laux; Jens Wiebe; Timm Bauer; Christian Hamm; Holger Nef
Journal:  Clin Res Cardiol       Date:  2014-10-18       Impact factor: 5.460

5.  [Renal sympathetic denervation can significantly reduce blood pressure and improve arterial stiffness in hypertensive beagles].

Authors:  F Ye; G Shi; X Wang; S Tu; Z Zhang; L Zeng
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2021-11-20

6.  Retinal microperfusion after renal denervation in treatment-resistant hypertensive patients.

Authors:  Christian Ott; Joanna M Harazny; Axel Schmid; Tilmann Ditting; Roland Veelken; Marek Bladowski; Georg Michelson; Michael Uder; Roland E Schmieder
Journal:  Clin Res Cardiol       Date:  2015-04-28       Impact factor: 5.460

Review 7.  Renal Nerve Stimulation as Procedural End Point for Renal Sympathetic Denervation.

Authors:  Annemiek F Hoogerwaard; Mark R de Jong; Arif Elvan
Journal:  Curr Hypertens Rep       Date:  2018-03-19       Impact factor: 5.369

Review 8.  Renal Denervation for Treatment of Hypertension: a Second Start and New Challenges.

Authors:  Alexandre Persu; Sverre Kjeldsen; Jan A Staessen; Michel Azizi
Journal:  Curr Hypertens Rep       Date:  2016-01       Impact factor: 5.369

9.  Percutaneous renal artery denervation in patients with chronic systolic heart failure: A randomized controlled trial.

Authors:  Jun-Qing Gao; Wei Yang; Zong-Jun Liu
Journal:  Cardiol J       Date:  2018-04-03       Impact factor: 2.737

Review 10.  Renal denervation for the management of resistant hypertension.

Authors:  Hitesh C Patel; Carl Hayward; Vassilis Vassiliou; Ketna Patel; James P Howard; Carlo Di Mario
Journal:  Integr Blood Press Control       Date:  2015-12-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.